Skip to content
StockMarketAgent
Direct answer
Salesforce is transitioning from a hyper-growth SaaS pioneer to a mature compounder. The thesis centers on a strategic shift from dilutive M&A to disciplined capital allocation, margin expansion, and robust free cash flow generation. Fair value range: low $172, high $303, with mid-point at $237.
Stock analysis

CRM Salesforce Inc. fair value $237–$303

CRM
By StockMarketAgent.AI team· supervised by
Przeanalizowano: 2026-05-09Następna aktualizacja: 2026-08-09Methodology v2.4Archetype: Mature compounderNYSE · Information Technology
View archive
Cena
$181.82
▲ +55.13 (+30.32%)
Wartość godziwa
$237
$237–$303
Rekomendacja
Zdecydowanie kupuj
confidence 88/100
Potencjał wzrostu
+30.3%
upside to fair value
Margines Bezpieczeństwa
$201.41
buy below · 15%
Kapitalizacja
$148.7B
P/E fwd 12.2
Awaryjny angielskiPL
Pokazujemy źródło angielskie podczas tłumaczenia
Ten raport nie został jeszcze przetłumaczony. Odśwież za kilka minut, gdy kolejka tłumaczeń go przetworzy.

§1 Podsumowanie wykonawcze

  • Transitioning to mature compounder focused on margin expansion and capital return.
  • Exceptional FCF supports aggressive share repurchases.
  • Market over-penalizing top-line fade; under-pricing cash economics.
  • Key risk is a return to undisciplined M&A or high SBC dilution.
Fair value
$237
Margin of safety
+23.3%
Confidence
88/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$181.82Price
FV $236.95
High $303.18

Salesforce is transitioning from a hyper-growth SaaS pioneer to a mature compounder. The thesis centers on a strategic shift from dilutive M&A to disciplined capital allocation, margin expansion, and robust free cash flow generation.

  • High switching costs within core
    High switching costs within core enterprise ecosystem
  • Deep integration of multi-cloud CRM
    Deep integration of multi-cloud CRM software
  • Cycle upside
    AI-driven product cycles reignite enterprise IT software spending.

§2 Scenariusz negatywny

A sustained macroeconomic downturn coupled with deep CRM saturation tests the model. If revenue growthRevenue growthYear-over-year change in revenue, expressed as a percentage. The starting point for any forward-earnings model and the lens through which scale, mix, and pricing power become visible. compresses below 5% and SBCStock-based compensationThe fair-value cost of equity awards (options, RSUs, performance shares) granted to employees. A real economic expense even though it is non-cash. remains elevated, true per-share value erodes despite optical cash generation.

Jak ta teza może się załamać

Growth Stagnation

20%· Medium

Core software markets saturate entirely, permanently capping top-line growth below 5%.

FV impact
-27%

M&A Relapse

15%· Low

Management abandons disciplined capital allocation, executing large dilutive acquisitions.

FV impact
-35%

AI Displacement

10%· Low

Agentforce fails to gain traction; nimble AI startups displace core service workflows.

FV impact
-20%
Sygnały wczesnego ostrzegania do monitorowania
WskaźnikBieżącyPróg wyzwalania
Revenue growth drops below 7% over two consecutive quarters.MonitorDeterioration versus the report thesis
Operating margins stall or compress below 30% target.MonitorDeterioration versus the report thesis
Share repurchases halted in favor of large-scale M&A.MonitorDeterioration versus the report thesis
Agentforce adoption rates disappoint internal targets.MonitorDeterioration versus the report thesis
SBC continues to consume outsized portion of operating cash flow.MonitorDeterioration versus the report thesis

§3 Historia finansowa

Rachunek zysków i strat — ostatnich sześć okresów
PozycjaT−0T−1T−2T−3T−4CAGR
Okres2022-01-312023-01-312024-01-312025-01-312026-01-31Trend
Przychody$26.49B$31.35B$34.86B$37.90B$41.53B+11.9%
Zysk brutto$19.47B$22.99B$26.32B$29.25B$32.26B+13.5%
Zysk operacyjny$548.0M$1.86B$6.00B$7.67B$8.92B+100.8%
Zysk netto$1.44B$208.0M$4.14B$6.20B$7.46B+50.7%
EPS (rozwodniony)$1.48$0.21$4.20$6.36$7.80+51.5%
EBITDA$3.85B$5.64B$9.96B$11.14B$12.55B+34.4%
R&D$4.47B$5.06B$4.91B$5.49B$5.99B+7.6%
SG&A$14.45B$16.08B$14.52B$15.19B$16.35B+3.1%

Wyniki jakości

Wskaźnik Piotroski F
7 / 9
Złożony wynik jakości 0–9
Wskaźnik Altman Z
2.49
Ryzyko upadłości (>3 bezpieczne)
Wskaźnik Beneish M
-2.66
Ryzyko manipulacji wynikami
OCF / Zysk netto
2.01×
>1 wskazuje wysoką jakość wyników
Bramka jakości księgowej
Pass
Bramka skorygowana o sektor
ROIC
9.2%
Zwrot z zainwestowanego kapitału
Sekcja 3

Numbers analysis

Alokacja kapitału

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

Subskrybenci indywidualni — od §411 kolejnych sekcji

Przeczytaj pełną analizę — 11 kolejnych sekcji.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Pełny raport dla każdego pokrytego tickera
24 miesiące archiwum rekomendacji
Briefingi watchlisty + alerty zmian rekomendacji
Eksport PDF + DOCX w dowolnym języku
Rozpocznij darmowy okres próbny
Anuluj w dowolnym momencie.
FAQ

CRM — frequently asked questions

  1. Based on our latest analysis, CRM looks meaningfully undervalued. The current price is $182 versus a composite fair-value midpoint of $237 (range $172–$303), which implies roughly 30.3% upside to the midpoint.
Related coverage

Names readers of CRM also follow

Same archetype: mature-compounder
Same sector: Information Technology